| Literature DB >> 31021519 |
Yuri A Zarate1, Katherine A Bosanko1, Aisling R Caffrey2, Jonathan A Bernstein3, Donna M Martin4, Marc S Williams5, Elizabeth M Berry-Kravis6, Paul R Mark7, Melanie A Manning8, Vikas Bhambhani9, Marcelo Vargas9, Andrea H Seeley5, Juvianee I Estrada-Veras10,11,12, Marieke F van Dooren13, Maria Schwab14, Adeline Vanderver15,16, Daniela Melis17, Adnan Alsadah18, Laurie Sadler19, Hilde Van Esch20, Bert Callewaert21, Ann Oostra22, Jane Maclean23, Maria Lisa Dentici24, Valeria Orlando25, Mark Lipson26, Steven P Sparagana27, Timothy J Maarup28, Suzanne Im Alsters29, Ariel Brautbar30, Eliana Kovitch31, Sakkubai Naidu32, Melissa Lees33, Douglas M Smith34, Lesley Turner35, Víctor Raggio36, Lucía Spangenberg37, Sixto Garcia-Miñaúr38, Elizabeth R Roeder39,40, Rebecca O Littlejohn39,40, Dorothy Grange41, Jean Pfotenhauer42, Marilyn C Jones43, Meena Balasubramanian44, Antonio Martinez-Monseny45, Lot Snijders Blok46,47, Ralitza Gavrilova48, Jennifer L Fish49.
Abstract
SATB2-associated syndrome (SAS) is an autosomal dominant neurodevelopmental disorder caused by alterations in the SATB2 gene. Here we present a review of published pathogenic variants in the SATB2 gene to date and report 38 novel alterations found in 57 additional previously unreported individuals. Overall, we present a compilation of 120 unique variants identified in 155 unrelated families ranging from single nucleotide coding variants to genomic rearrangements distributed throughout the entire coding region of SATB2. Single nucleotide variants predicted to result in the occurrence of a premature stop codon were the most commonly seen (51/120 = 42.5%) followed by missense variants (31/120 = 25.8%). We review the rather limited functional characterization of pathogenic variants and discuss current understanding of the consequences of the different molecular alterations. We present an expansive phenotypic review along with novel genotype-phenotype correlations. Lastly, we discuss current knowledge of animal models and present future prospects. This review should help provide better guidance for the care of individuals diagnosed with SAS.Entities:
Keywords: SATB2; SATB2-associated syndrome; genotype-phenotype correlation; pathogenic variants; whole exome sequencing
Mesh:
Substances:
Year: 2019 PMID: 31021519 DOI: 10.1002/humu.23771
Source DB: PubMed Journal: Hum Mutat ISSN: 1059-7794 Impact factor: 4.878